Search
Results: 2
Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19
Matthew A Rutherford, Jennifer Scott, Maira Karabayas, Marilina Antonelou, Seerapani Gopaluni, David Gray, Joe Barrett, Silke R Brix, Neeraj Dhaun, Stephen P McAdoo, Rona M Smith, Colin C Geddes, David Jayne, Raashid Luqmani, Alan D Salama, Mark A Little, Neil Basu, UK and Ireland Vasculitis Rare Disease Group (UKIVAS)
Nov 15, 2021
OBJECTIVE: COVID-19 is a novel infectious disease with a broad spectrum of clinical severity. Patients with systemic vasculitis have an increased risk of serious infections and may be at risk of severe outcomes following...
Aged Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis covid-19 Comorbidity Female Glucocorticoids Hospitalization Humans Immunosuppressive Agents Intensive Care Units Male Middle Aged Odds Ratio Oxygen Inhalation Therapy Registries Respiration Artificial Respiratory Tract Diseases Risk Factors SARS-CoV-2 Severity of Illness Index Systemic Vasculitis
Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID‐19
Matthew A. Rutherford, Jennifer Scott, Maira Karabayas, Marilina Antonelou, Seerapani Gopaluni, David Gray, Joe Barrett, Silke R. Brix, Neeraj Dhaun, Stephen P. McAdoo, Rona M. Smith, Colin C. Geddes, David Jayne, Raashid Luqmani, Alan D. Salama, Mark A. Little, Neil Basu, the UK and Ireland Vasculitis Rare Disease Group (UKIVAS)
Jul 28, 2021
Published by: Arthritis & Rheumatology